PHA-767491

CAS No. 845714-00-3

PHA-767491 ( CAY10572 )

Catalog No. M19170 CAS No. 845714-00-3

PHA-767491 is a potent ATP-competitive dual Cdc7/CDK9 inhibitor with IC50 of 10 nM and 34 nM, respectively.

Purity : 98%

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 27 In Stock
5MG 41 In Stock
10MG 57 In Stock
25MG 122 In Stock
50MG 212 In Stock
100MG 383 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    PHA-767491
  • Note
    Research use only, not for human use.
  • Brief Description
    PHA-767491 is a potent ATP-competitive dual Cdc7/CDK9 inhibitor with IC50 of 10 nM and 34 nM, respectively.
  • Description
    PHA-767491 is a potent ATP-competitive dual Cdc7/CDK9 inhibitor with IC50 of 10 nM and 34 nM, respectively.
  • Synonyms
    CAY10572
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Cdc7; CDK1; CDK2; CDK9; GSK-3β
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    845714-00-3
  • Formula Weight
    213.24
  • Molecular Formula
    C12H11N3O
  • Purity
    98%
  • Solubility
    ——
  • SMILES
    C1CNC(=O)c2c1[nH]c(c2)c1ccncc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Montagnoli A, et al. Nat Chem Biol, 2008, 4(6), 357-365.
molnova catalog
related products
  • 8-Epideoxyloganic ac...

    8-Epideoxyloganic acid possesses bioactivities of analgesia, homeostasis and anti-inflammatory. It has the potential to serve as anti-inflammatory agents during oxidative stress, the inhibition of ROS production, possibly through modulation of NOX activity and/or the radical scavenging effect, and beta2 integrin expression in leucocytes.

  • Siaresinolic acid 28...

    Siaresinolic acid 28-O-β-D-glucopyranosyl ester is a natural product for research related to life sciences.

  • IMR-1

    IMR-1 is a novel class of Notch inhibitors targeting the transcriptional activation with IC50 of 6 μMol/L.